Layered double hydroxide modified by PEGylated hyaluronic acid as a hybrid nanocarrier for targeted drug delivery

Abstract

In recent years, organic-inorganic hybrid nanocarriers are explored for effective drug delivery and preferable disease treatments. In this study, using 5-fluorouracil(5-FU)as electronegative model drug, a new type of organic-inorganic hybrid drug delivery system(LDH/HA-PEG/5-FU)was conceived and manufactured by the adsorption of PEGylated hyaluronic acid(HA-PEG)on the surface of layered double hydroxide(LDH, prepared via hydrothermal method)and the intercalation of 5-FU in the interlamination of LDH via ion exchange strategy. The drug loading amount of LDH/HA-PEG/5-FU achieved as high as 34.2%. LDH, LDH/5-FU and LDH/HA-PEG/5- FU were characterized by FT-IR, XRD, TGA, laser particle size analyzer and SEM. With the benefit of pHdegradable feature of LDH and enzyme-degradable feature of HA, LDH/HA-PEG/5-FU showed pH-degradable and enzyme-degradable capacity in in vitro drug release. Moreover, the drug carrier LDH/HA-PEG contained biocompatible PEG and tumor-targeted HA, resulting in lower cytotoxicity and better endocytosis compared with LDH in vitro. It was suggested that the organic-inorganic hybrid drug delivery system, which was endowed with the properties of controlled release, low toxicity and tumor-targeting delivery for ameliorative cancer therapy, was advisable and might be applied further to fulfill other treatments.

Keywords

layered double hydroxide / HA-PEG, intercalation/adsorption / controlled release / targeted drug delivery

References

[1] Allen T M, Cullis P R. Drug delivery systems: Entering the mainstream[J]. Science, 2004, 303(5665): 1818-1822.

[2] Han S, Wan H, Lin D, et al. Contribution of hydrophobic/hydrophilic modification on cationic chains of poly(epsilon-caprolactone)-graft-poly(dimethylamino ethylmethacrylate) amphiphilic co-polymer in gene delivery[J]. Acta Biomaterialia, 2014, 10(2): 670-679.

[3] Chiang Y T, Lo C L. pH-responsive polymer-liposomes for intracellular drug delivery and tumor extracellular matrix switched-on targeted cancer therapy[J]. Biomaterials, 2014, 35(20): 5414-5424.

[4] Gifford I, Vreeland W, Grdanovska S, et al. Liposome based delivery of a boron-containing cholesteryl ester for high-LET particle-induced damage of prostate cancer cells: A boron neutron capture therapy study[J]. International Journal of Radiation Biology, 2014, 90(6): 480-485.

[5] Khatri N, Baradia D, Vhora I, et al. cRGD grafted liposomes containing inorganic nano-precipitate complexed siRNA for intracellular delivery in cancer cells[J]. Journal of Controlled Release, 2014, 182: 45-57.

[6] Jeong B, Bae Y H, Lee D S, et al. Biodegradable block copolymers as injectable drug-delivery systems[J]. Nature, 1997, 388(6645): 860-862.

[7] Mathiowitz E, Jacob J S, Jong Y S, et al. Biologically erodable microspheres as potential oral drug delivery systems[J]. Nature, 1997, 386(6623): 410-414.

[8] Mundargi R C, Babu V R, Rangaswamy V, et al. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives[J]. Journal of Controlled Release, 2008, 125(3): 193-209.

[9] Kreilgaard M. Influence of microemulsions on cutaneous drug delivery[J]. Advanced Drug Delivery Reviews, 2002, 54: S77-S98.

[10] Chen M L, He Y J, Chen X W, et al. Quantum dots conjugated with Fe₃O₄-filled carbon nanotubes for cancertargeted imaging and magnetically guided drug delivery[J]. Langmuir, 2012, 28(47): 16469-16476.

[11] Jiang Z L, Dong B, Chen B T, et al. Multifunctional Au@mSiO₂/rhodamine B isothiocyanate nanocomposites: Cell imaging, photocontrolled drug release, and photothermal therapy for cancer cells[J]. Small, 2013, 9(4): 604-612.

[12] Samanta B, Yan H, Fischer N O, et al. Protein-passivated Fe₃O₄ nanoparticles: Low toxicity and rapid heating for thermal therapy[J]. Journal of Materials Chemistry, 2008, 18(11): 1204-1208.

[13] Xuan S H, Wang F, Lai J M Y, et al. Synthesis of biocompatible, mesoporous Fe₃O₄ nano/microspheres with large surface area for magnetic resonance imaging and therapeutic applications[J]. ACS Applied Materials & Interfaces, 2011, 3(2): 237-244.

[14] Yu T, Malugin A, Ghandehari H. Impact of silica nanoparticle design on cellular toxicity and hemolytic activity[J]. ACS Nano, 2011, 5(7): 5717-5728.

[15] Kim J, Lee J E, Lee S H, et al. Designed fabrication of a multifunctional polymer nanomedical platform for simultaneous cancer-targeted imaging and magnetically guided drug delivery[J]. Advanced Materials, 2008, 20(3): 478-491.

[16] Yang X, Zhang X, Ma Y, et al. Superparamagnetic graphene oxide-Fe₃O₄ nanoparticles hybrid for controlled targeted drug carriers[J]. Journal of Materials Chemistry, 2009, 19(18): 2710-2714.

[17] Chen Y, Chen H, Zeng D, et al. Core/shell structured hollow mesoporous nanocapsules: A potential platform for simultaneous cell imaging and anticancer drug delivery[J]. ACS Nano, 2010, 4(10): 6001-6013.

[18] Choudary B M, Madhi S, Chowdari N S, et al. Layered double hydroxide supported nanopalladium catalyst for Heck-, Suzuki-, Sonogashira-, and Stille-type coupling reactions of chloroarenes[J]. Journal of the American Chemical Society, 2002, 124(47): 14127-14136.

[19] Costa F R, Wagenknecht U, Heinrich G. LDPE/Mg-Al layered double hydroxide nanocomposite: Thermal and flammability properties[J]. Polymer Degradation and Stability, 2007, 92(10): 1813-1823.

[20] Wang Z Y, Han E H, Ke W. Influence of nano-LDHs on char formation and fire-resistant properties of flameretardant coating[J]. Progress in Organic Coatings, 2005, 53(1): 29-37.

[21] Liu J, Li Y, Huang X, et al. Layered double hydroxide nano-and microstructures grown directly on metal substrates and their calcined products for application as Liion battery electrodes[J]. Advanced Functional Materials, 2008, 18(9): 1448-1458.

[22] Gao Z, Wang J, Li Z, et al. Graphene nanosheet/Ni²⁺/Al³⁺ layered double-hydroxide composite as a novel electrode for a supercapacitor[J]. Chemistry of Materials, 2011, 23(15): 3509-3516.

[23] Wang L, Wang D, Dong X Y, et al. Layered assembly of graphene oxide and Co-Al layered double hydroxide nanosheets as electrode materials for supercapacitors[J]. Chemical Communications, 2011, 47(12): 3556-3558.

[24] Evans D G, Xue D A. Preparation of layered double hydroxides and their applications as additives in polymers, as precursors to magnetic materials and in biology and medicine[J]. Chemical Communications, 2006, 37(5): 485-496.

[25] Sideris P J, Nielsen U G, Gan Z, et al. Mg/Al ordering in layered double hydroxides revealed by multinuclear NMR spectroscopy[J]. Science, 2008, 321(5885): 113-117.

[26] You Y W, Vance G F, Zhao H T. Selenium adsorption on Mg-Al and Zn-Al layered double hydroxides[J]. Applied Clay Science, 2001, 20(1/2): 13-25.

[27] Khan A I, Lei L X, Norquist A J, et al. Intercalation and controlled release of pharmaceutically active compounds from a layered double hydroxide[J]. Chemical Communications, 2001, 37(22): 2342-2343.

[28] Choy J H, Jung J S, Oh J M, et al. Layered double hydroxide as an efficient drug reservoir for folate derivatives[J]. Biomaterials, 2004, 25(15): 3059-3064.

[29] Rojas R, Jimenez-Kairuz A F, Manzo R H, et al. Release kinetics from LDH-drug hybrids: Effect of layers stacking and drug solubility and polarity[J]. Colloids and Surfaces A: Physicochemical and Engineering Aspects, 2014, 463: 37-43.

[30] Li B X, He J, Evans D G, et al. Inorganic layered double hydroxides as a drug delivery system—Intercalation and in vitro release of fenbufen[J]. Applied Clay Science, 2004, 27(3/4): 199-207.

[31] Ladewig K, Niebert M, Xu Z P, et al. Efficient siRNA delivery to mammalian cells using layered double hydroxide nanoparticles[J]. Biomaterials, 2010, 31(7): 1821-1829.

[32] Wong Y, Markham K, Xu Z P, et al. Efficient delivery of siRNA to cortical neurons using layered double hydroxide nanoparticles[J]. Biomaterials, 2010, 31(33): 8770-8779.

[33] Desigaux L B, Belkacem M, Richard P, et al. Selfassembly and characterization of layered double hydroxide/DNA hybrids[J]. Nano Letters, 2006, 6(2): 199-204.

[34] Li L, Gu W Y, Chen J Z, et al. Co-delivery of siRNAs and anti-cancer drugs using layered double hydroxide nanoparticles[J]. Biomaterials, 2014, 35(10): 3331-3339.

[35] Xu Z P, Stevenson G S, Lu C Q, et al. Stable suspension of layered double hydroxide nanoparticles in aqueous solution[J]. Journal of the American Chemical Society, 2006, 128(1): 36-37.

[36] Zhang W, Cheng Q, Guo S, et al. Gene transfection efficacy and biocompatibility of polycation/DNA complexes coated with enzyme degradable PEGylated hyaluronic acid[J]. Biomaterials, 2013, 34(27): 6495-6503.

[37] Wu X, Li H, Song S, et al. Facile synthesis of camptothecin intercalated layered double hydroxide nanohybrids via a coassembly route[J]. International Journal of Pharmaceutics, 2013, 454(1): 453-461.

[38] Pan C, Shen L, Shang S, et al. Preparation of superhydrophobic and UV blocking cotton fabric via solgel method and self-assembly[J]. Applied Surface Science, 2012, 259: 110-117.

[39] Lin X N, Deng L D, Xu Y S, et al. Thermosensitive in situ hydrogel of paclitaxel conjugated poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) [J]. Soft Matter, 2012, 8(12): 3470-3477.

[40] Azhar F F, Olad A. A study on sustained release formulations for oral delivery of 5-fluorouracil based on alginate-chitosan/montmorillonite nanocomposite systems [J]. Applied Clay Science, 2014, 101: 288-296.

[41] Monash P, Pugazhenthi G. Utilization of calcined Ni-Al layered double hydroxide (LDH) as an adsorbent for removal of methyl orange dye from aqueous solution[J]. Environmental Progress & Sustainable Energy, 2014, 33(1): 154-159.

[42] Tannock I F, Rotin D. Acid pH in tumors and its potential for therapeutic exploitation[J]. Cancer Research, 1989, 49(16): 4373-4384.

[43] Picart C, Schneider A, Etienne O, et al. Controlled degradability of polysaccharide multilayer films in vitro and in vivo[J]. Advanced Functional Materials, 2005, 15(11): 1771-1780.

[44] Ghosh P, Guidolin D. Potential mechanism of action of intra-articular hyaluronan therapy in osteoarthritis: Are the effects molecular weight dependent?[J]. Seminars in Arthritis and Rheumatism, 2002, 32(1): 10-37.